Prostate Cancer News

The Cancer Clinical Trials Center at The Cancer Institute of New Jersey at Cooper offers more than 100 phase II, III, and IV clinical trials in virtually all types of cancer each year—the largest cancer clinical trials program in South Jersey. “It’s been proven that all patients at cancer programs which offer clinical trials, not just those who participate in the trials, receive better care than those at programs which do not offer clinical trials,” said Robert A. Somer, MD, a Medical Oncologist and Director of the Hematology/Medical Oncology Clinical Trials Program within The Cancer Clinical Trials Center. read more...

03/14/2005 - NIH-Sponsored Prostate Cancer Brachytherapy Study Available Only at Cooper The Cancer Institute of New Jersey at Cooper is now enrolling patients with localized prostate cancer in a prospective phase II study to evaluate the use of magnetic resonance spectroscopic imaging (MRSI) in prostate brachytherapy. Cooper is the only site in the nation for this study, which is being conducted under a $1.2 million NIH RO1 grant. read more...

03/14/2005 - NIH-Sponsored Study for Men with Prostate Cancer - The Cancer Institute of New Jersey at Cooper The Cancer Institute of New Jersey at Cooper is now enrolling some patients with prostate cancer in a National Institutes of Health (NIH)-sponsored study that is using a novel imaging technology called magnetic resonance spectroscopic imaging (MRSI) to deliver brachytherapy. Cooper is the only site in the nation where this study is available. read more...

02/16/2005 - Invisible Scalpel Treating Tumors Throughout Entire Body The Cancer Institute of New Jersey at Cooper (CINJ at Cooper) is now offering a precise radiation treatment for tumors throughout the whole body. Body Radio Surgery, a new technique being used by radiation oncologists at Cooper, is like an “invisible scalpel” that treats tumors without having to undergo surgery. read more...

04/14/2004 - DiBiase Using New Radiation Procedure on Brain Tumors Steven J. DiBiase, MD, Chief of Radiation Oncology at Cooper University Hospital is performing Stereotactic Radiosurgery (SRS), a new radiation treatment using an “X-Knife” SRS machine. This machine delivers radiosurgery to a specific place in the brain, pin-pointing the tumor to treat the cancer. Studies are showing that this minimally invasive treatment is just as effective as surgery with fewer side effects. It is an outpatient